PLA2G7介导脂质相关巨噬细胞促炎活化驱动牙髓炎
该研究整合单细胞RNA测序、脂质组学和批量RNA测序,刻画牙髓炎中巨噬细胞亚群及代谢改变,发现高表达PLA2G7的脂质相关巨噬细胞亚群随炎症严重度增加。体外抑制PLA2G7可抑制炎症反应,补充LPC削弱此效应;小鼠模型中达普拉地布抑制PLA2G7减轻牙髓炎进展。机制上JUND可能经液-液相分离调控PLA2G7,形成JUND-PLA2G7-LPC信号轴。
要点
- 牙髓炎中高表达PLA2G7的脂质相关巨噬细胞亚群随炎症严重度增加。
- 抑制PLA2G7可抑制巨噬细胞炎症活化,LPC补充可削弱该抗炎效应。
- 达普拉地布抑制PLA2G7可减轻小鼠牙髓炎进展和巨噬细胞活化。
核心结论
- PLA2G7是牙髓炎的潜在生物标志物,JUND-PLA2G7-LPC信号轴连接脂质代谢与巨噬细胞介导的炎症反应,为保存牙髓活力提供新视角。
研究设计与样本
- 研究采用单细胞RNA测序、脂质组学和批量RNA测序整合分析牙髓炎中巨噬细胞亚群与代谢改变。
- 用Western blot和免疫荧光验证人牙髓组织中PLA2G7表达。
- 体外建立炎症THP-1巨噬细胞模型,研究PLA2G7抑制和LPC补充对炎症活化的影响。
- 用生物信息学分析和FRAP实验探索PLA2G7上游转录调控机制。
- 采用达普拉地布治疗的鼠牙髓炎模型评估抗炎效果。
主要发现
- 单细胞RNA测序、脂质组学和RNA测序鉴定出牙髓炎中高表达PLA2G7的独特脂质相关巨噬细胞亚群,其丰度随炎症严重度增加。
- 免疫荧光和Western blot验证牙髓炎组织中脂质相关巨噬细胞PLA2G7表达升高。
- 体外抑制PLA2G7显著抑制炎症反应,而补充LPC削弱此抗炎效应。
- 体内达普拉地布抑制PLA2G7显著减轻小鼠牙髓炎进展并减少巨噬细胞活化。
- 生物信息学分析鉴定JUND为PLA2G7的转录调控因子,可能经液-液相分离介导的转录凝聚体发挥作用。
临床怎么用
- PLA2G7可作为牙髓炎潜在生物标志物,用于评估炎症严重度。
- 达普拉地布抑制PLA2G7在鼠模型中减轻牙髓炎进展,提示靶向该通路可能有助于保存牙髓活力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Pulpitis is a common and painful disease characterised by complex and dynamic immune responses and may lead to irreversible tissue damage or tooth loss. Macrophages act as key sentinels that exhibit differential metabolic reprogramming, tightly orchestrating the immune microenvironment. However, the specific metabolic mechanisms governing macrophage-driven inflammatory activation in pulpitis remain unclear. Here, we reveal a specific lipid metabolism-driven immune pathway within macrophages in pulpitis. METHODOLOGY: An integrative analysis of single-cell RNA sequencing (scRNA-seq), lipidomics and bulk RNA sequencing (RNA-seq) was employed to characterise macrophage subpopulations and metabolic alterations in pulpitis. Western blot and immunofluorescence staining were performed to validate the expression of phospholipase A2 group VII (PLA2G7) in human pulp tissues. In vitro, an inflammatory THP-1 macrophage model was established to investigate the effects of PLA2G7 inhibition and lysophosphatidylcholine (LPC) supplementation, and macrophage inflammatory activation was assessed by RT-qPCR, Western blot, ELISA and immunofluorescence staining. Bioinformatic analyses and fluorescence recovery after photobleaching (FRAP) experiments were conducted to identify the upstream transcriptional regulator of PLA2G7 and explore its regulatory mechanism. A murine pulpitis model treated with the PLA2G7 inhibitor darapladib was used to evaluate the anti-inflammatory effects by ELISA, immunohistochemical and immunofluorescence staining. RESULTS: ScRNA-seq, lipidomics and RNA-seq analyses identified a distinct lipid-associated macrophage subset with high PLA2G7 expression in pulpitis. The abundance of this subset increased with inflammatory severity. Immunofluorescence and Western blot validated increased PLA2G7 expression in lipid-associated macrophages in pulpitis tissues. In vitro, inhibition of PLA2G7 significantly suppressed inflammatory responses, whereas supplementation with LPC attenuated this anti-inflammatory effect. In vivo, darapladib-mediated inhibition of PLA2G7 significantly attenuated pulpitis progression and reduced macrophage activation in mice. Mechanistically, integrative bioinformatic analysis identified JunD proto-oncogene (JUND) as a transcriptional regulator of PLA2G7, potentially via liquid-liquid phase separation (LLPS)-mediated transcriptional condensates. CONCLUSIONS: These findings identify PLA2G7 as a potential biomarker for pulpitis and reveal a JUND-PLA2G7-LPC signalling axis linking lipid metabolism to macrophage-mediated inflammatory responses, providing a novel perspective for preserving dental pulp vitality.
引用
- Chen X, Huang X, Lian C, et al. PLA2G7-Mediated Pro-Inflammatory Activation of Lipid-Associated Macrophages Drives Pulpitis. Int Endod J. 2026. PMID: 42693816. doi:10.1111/iej.70264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。